12 December 2000 from Dr. Korba that is said to show that certain tested
samples, including BCH- 189, exhibited anti-HBV activity. (Exh.2019),
51. Dr. Biron testified that she received the report from Dr. Korba on 12 Deccrer
1990. (Exh. 2050 at 17).
52. Furman has submitted evidence that appears to be a report dated
14 December 2000 from Dr. Korba that is said to show that certain tested
samples, including BCH- 189, exhibited anti-HBV activity. (Exh.2014).
53. Ms. Kondy testified that she received the report from Dr. Korba on
14 December 1990. (Exh. 2052 at 18).
54. Dr. Biron and Ms. Kondy each testified that she prepared a memorandum
reporting the anti-HBV activity of several compounds, including
BCH-189. (Exh. 2050 at 18 and Exh. 2052 at ý 8).
55. Furman has submitted evidence that appears to be a memorandum dated
28 December 1990. The memorandum indicates that BCH-l 89
demonstrated anti-HBV activity in Dr. Korba's test. (Exh. 2015).
56. The Furman inventors are listed on the distribution list for the memorandum.
(Exh. 2015).
57. Dr. Furman did not testify that he received or read the memorandum.
58. Ms. Kondy testified that "sometimes" she or Dr. Biron would verbally
communicate test results to chemists who submitted compounds for testing.
(Exh. 2052 at 15). However, Ms. Kondy did not testify that either of the Fur-man
inventors submitted BCH-1 89 for anti-HBV testing or that she verbally
18
Page: Previous 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 Next
Last modified: November 3, 2007